RxDoctor Payments Data

Vindya Jeyaretnam, DO

Family Medicine · Sanford, NCNPI 1821445123

Payments from drug & device makers

$1,835in general payments, 2019–2025

Across 108 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$921
  • Lilly USA, LLC$167
  • AbbVie$147
  • Amgen$91
  • Otsuka America Pharmaceutical, Inc.$65
  • Pfizer$50
  • plus $392 from 14 others

What the payments were for

  • Food & beverage$1,835100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,835 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$34,821
Medicare patients
93
Services billed
728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$65,741
JardianceEmpagliflozin24$31,887
EliquisApixaban17$24,976
FarxigaDapagliflozin Propanediol17$15,771
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$14,173
TrintellixVortioxetine Hydrobromide11$9,201
Repatha SureclickEvolocumab12$6,766
MyrbetriqMirabegron14$5,459
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$4,394
Atorvastatin Calcium262$2,935
Celecoxib13$2,288
Albuterol Sulfate HfaAlbuterol Sulfate64$2,153
SynthroidLevothyroxine Sodium14$1,911
Pantoprazole Sodium74$1,241
Bupropion XlBupropion Hcl34$877

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$921$65,74150 claims
PfizerEliquis$50$24,97617 claims
AstraZenecaFarxiga$32$15,77117 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$36$9,20111 claims
Astellas Pharma US IncMyrbetriq$17$5,45914 claims
AbbVieSynthroid$147$1,91114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Sanford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →